New patent for Arcutis drug ZORYVE

Annual Drug Patent Expirations for ZORYVE

Zoryve is a drug marketed by Arcutis and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug.

ZORYVE drug price trends.

This drug has forty-two patent family members in twelve countries.

The generic ingredient in ZORYVE is roflumilast. One supplier is listed for this compound. Additional details are available on the roflumilast profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com